Pain Science Education Administered in Full or Fractioned Dosage Modes for Temporomandibular Disorders
Launched by UNIVERSIDADE FEDERAL DE SAO CARLOS · Feb 6, 2024
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different ways of delivering pain education can help people with Temporomandibular Disorders (TMD), which cause pain in the jaw and surrounding areas. The researchers want to see if offering pain education in two longer sessions of 45 minutes each is more effective than giving it in smaller, more frequent sessions of 15 minutes over six visits. Both groups will also receive manual therapy and exercises to help with their condition. The trial will involve 148 participants aged 20 to 60 who have had pain for at least three months and are fluent in Portuguese.
If you join the study, you’ll be randomly placed into one of the two groups and will attend sessions twice a week for eight weeks. Throughout the study, researchers will check how your pain and ability to function are affected by the treatment, as well as other factors like your understanding of pain and how you feel about your recovery. This study is not yet recruiting participants, but if you meet the criteria and are interested, it could be a great opportunity to receive support for your TMD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age between 20 and 60 years;
- • painful TMD (confirmed by applying DC/TMD);
- • complaint of pain with a minimum intensity of 3 (on a scale of 0 to 10) present for at least 3 months;
- • fluency to speak and understand Brazilian Portuguese (Mini Cog instrument to assess cognitive capacity and the Cloze Test to certify textual reading comprehension)
- Exclusion Criteria:
- • history of tumors in the orofacial region;
- • central and peripheral neurological diseases;
- • uncontrolled psychiatric illnesses;
- • pregnant women;
- • presence of toothache, neuralgia or chronic painful conditions in the head region, orofacial region or systemic pain (for example, fibromyalgia, osteoarthritis, osteoarthritis or rheumatological diseases);
- • report of previous major surgeries in the craniofacial region, such as orthognathic surgeries, TMJ surgeries, or resulting from post-trauma corrections;
- • history of major trauma involving the cervical or craniofacial region (facial trauma, whiplash injuries, etc.);
- • individuals undergoing physiotherapeutic treatment up to 6 months before the start of this study.
About Universidade Federal De Sao Carlos
The Universidade Federal de São Carlos (UFSCar) is a leading Brazilian institution dedicated to advancing research and education in the fields of science, technology, and health. With a strong emphasis on innovation and interdisciplinary collaboration, UFSCar fosters a vibrant academic environment that supports clinical trials aimed at addressing pressing health challenges. The university's commitment to high standards of ethical research and community engagement ensures that its clinical trials contribute valuable insights to the scientific community while promoting the well-being of diverse populations. Through its robust infrastructure and experienced research teams, UFSCar plays a pivotal role in advancing medical knowledge and improving patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Carlos, São Paulo, Brazil
São Carlos, Brazil
Patients applied
Trial Officials
Thais Chaves, Ph.D
Study Chair
Federal University of São Carlos - UFSCar
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported